UNITED STATES SECURITIES AND EXCHANGE COMMISSION    
                        Washington, D.C. 20549     
     
                              FORM 10-K/A    
    
/X/     Annual Report Pursuant to Section 13 or 15(d) of the    
        Securities Exchange Act of 1934     
    
        For the Fiscal Year Ended December 31, 1996     
    
/ /     Transition Report Pursuant to Section 13 or 15(d) of the    
        Securities Exchange Act of 1934    
    
        For the transition period from           to     
                  Commission File Number 2-89332    
    
               INTERFERON SCIENCES RESEARCH PARTNERS, LTD.    
         (Exact name of registrant as specified in its charter)    
    
    New Jersey                                      22-2502556    
(State or other jurisdiction of                    (I.R.S. Employer    
 incorporation or organization)                     Identification No.)    
   
   
783 Jersey Avenue, New Brunswick, New Jersey         08901   
(Address of principal executive offices)            (Zip Code)   
   
Registrant's telephone number, including area code: (908) 249-3250   
   
Securities registered pursuant to Section 12(g) of the Act: None    
   
   
     Indicate by check mark whether the registrant (1) has filed   
all reports required to be filed by Section 13 or 15(d) of the   
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the Registrant was required to file   
such reports), and (2) has been subject to such filing   
requirements for the past 90 days.   
    
                   Yes     X            No   
  
  
   



                          Index to Exhibits


Exhibit No.                  Description

27                       Financial Data Schedule